World's Best Scientists 2026 revealed!
Sarah S. Donaldson

Sarah S. Donaldson

Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
108
Citations
39730
World Ranking
984
National Ranking
599

Medicine

D-Index
108
Citations
41368
World Ranking
6023
National Ranking
3220

Sarah S. Donaldson publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Sarah S. Donaldson sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 497 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Sarah S. Donaldson D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Sarah S. Donaldson sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 108 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award
  • 2012 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 2005 - Elizabeth Blackwell Medal, American Medical Women's Association
  • 1999 - Member of the National Academy of Medicine (NAM)

Overview

Sarah S. Donaldson is affiliated with Stanford University in the United States. Their primary field of study is Medicine, with a specific focus on subfields such as Pulmonary and Respiratory Medicine, Oncology, Surgery, Pathology and Forensic Medicine, and Pediatrics, Perinatology, and Child Health.

Their research covers several topics, with an emphasis on Sarcoma Diagnosis and Treatment, Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Tumors and Oncological Cases, Advances in Oncology and Radiotherapy, Advanced Radiotherapy Techniques, and Cancer Diagnosis and Treatment.

Several of their recent papers include:

  • An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials (2022), published in Pediatric Blood & Cancer
  • Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation (2021), Journal of Clinical Oncology
  • Continuing Medical Student Education During the Coronavirus Disease 2019 (COVID-19) Pandemic: Development of a Virtual Radiation Oncology Clerkship (2020), Advances in Radiation Oncology
  • Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group (2022), Pediatric Blood & Cancer
  • Rhabdomyosarcoma (2021), Pediatric Blood & Cancer

Frequent coauthors include:

  • Susan M. Hiniker
  • Paulina M. Gutkin
  • Rie von Eyben
  • Rajkumar Venkatramani
  • Matthew J. Krasin

Their work has been published often in the following venues:

  • Pediatric Blood & Cancer
  • International Journal of Radiation Oncology*Biology*Physics
  • Advances in Radiation Oncology
  • Journal of Clinical Oncology
  • Practical Radiation Oncology

Sarah S. Donaldson has contributed to book publications including "Radiation Therapy of Benign Diseases" published by Springer Nature in 2023.

The scientist has been recognized with several awards, including:

  • Fellow of the American Association for the Advancement of Science (AAAS), 2012
  • Elizabeth Blackwell Medal, American Medical Women's Association, 2005
  • Member of the National Academy of Medicine (NAM), 1999

Best Publications

  • Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.

    Holcombe E Grier;Mark D Krailo;Nancy J Tarbell;Michael P Link

  • The Third Intergroup Rhabdomyosarcoma Study.

    W Crist;E A Gehan;A H Ragab;P S Dickman

  • Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease

    William M. Crist;James R. Anderson;Jane L. Meza;Christopher Fryer

  • Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort.

    Daniel A Mulrooney;Mark W Yeazel;Toana Kawashima;Ann C Mertens

  • The intergroup rhabdomyosarcoma study-II

    Harold M. Maurer;Harold M. Maurer;Edmund A. Gehan;Mohan Beltangady;William Crist

  • Second Malignant Neoplasms in Five-Year Survivors of Childhood Cancer: Childhood Cancer Survivor Study

    Joseph P. Neglia;Debra L. Friedman;Yutaka Yasui;Ann C. Mertens

  • Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project.

    Leslie L. Robison;Ann C. Mertens;John D. Boice;Norman E. Breslow

  • Subsequent Neoplasms in 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor Study

    Debra L. Friedman;John Whitton;Wendy Leisenring;Wendy Leisenring;Ann C. Mertens

  • The Childhood Cancer Survivor Study: A National Cancer Institute–Supported Resource for Outcome and Intervention Research

    Leslie L. Robison;Gregory T. Armstrong;John D. Boice;Eric J. Chow

  • New Primary Neoplasms of the Central Nervous System in Survivors of Childhood Cancer: a Report From the Childhood Cancer Survivor Study

    Joseph P. Neglia;Leslie L. Robison;Marilyn Stovall;Yan Liu

  • Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study.

    Gregory T. Armstrong;Qi Liu;Yutaka Yasui;Sujuan Huang

  • Second Neoplasms in Survivors of Childhood Cancer: Findings From the Childhood Cancer Survivor Study Cohort

    Anna T. Meadows;Debra L. Friedman;Joseph P. Neglia;Ann C. Mertens

  • Fertility of Female Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study

    Daniel M. Green;Toana Kawashima;Marilyn Stovall;Wendy Leisenring

  • Cardiac disease following treatment of Hodgkin's disease in children and adolescents.

    S L Hancock;S S Donaldson;R T Hoppe

  • Prognostic Factors and Clinical Outcomes in Children and Adolescents With Metastatic Rhabdomyosarcoma—A Report From the Intergroup Rhabdomyosarcoma Study IV

    John C. Breneman;Elizabeth Lyden;Alberto S. Pappo;Michael P. Link

  • Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.

    R. Raney;James Anderson;Frederic Barr;Sarah Donaldson

  • Pregnancy outcome of female survivors of childhood cancer: A report from the childhood cancer survivor study☆☆☆★

    Daniel M. Green;John A. Whitton;Marilyn Stovall;Ann C. Mertens

  • Fertility of Male Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study

    Daniel M. Green;Toana Kawashima;Marilyn Stovall;Wendy Leisenring

  • Medical Care in Long-Term Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study

    Paul C. Nathan;Mark L. Greenberg;Kirsten K. Ness;Melissa M. Hudson

  • Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803.

    Carola A.S. Arndt;Julie A. Stoner;Douglas S. Hawkins;David A. Rodeberg

Frequent Co-Authors

Michael P. Link
Michael P. Link Stanford University
Leslie L. Robison
Leslie L. Robison St. Jude Children's Research Hospital
Marilyn Stovall
Marilyn Stovall The University of Texas MD Anderson Cancer Center
Suzanne L. Wolden
Suzanne L. Wolden Memorial Sloan Kettering Cancer Center
Wendy Leisenring
Wendy Leisenring Fred Hutchinson Cancer Research Center
Nancy J. Tarbell
Nancy J. Tarbell Harvard University
Joseph P. Neglia
Joseph P. Neglia University of Minnesota
Charles A. Sklar
Charles A. Sklar Memorial Sloan Kettering Cancer Center
Melissa M. Hudson
Melissa M. Hudson St. Jude Children's Research Hospital
David M. Parham
David M. Parham Children's Hospital of Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn’t always have to follow the traditional route of medical school. Today, there are numerous online degree options for those interested in healthcare. For example, nurses seeking advanced roles can explore the shortest dnp programs online, which offer a faster route to doctoral-level expertise.

Flexibility is another major advantage. Many online dnp programs allow you to study at your own pace, making them accessible for working professionals.

Those looking to start a nursing career quickly may be interested in a 6 month lpn program. These programs help students become Licensed Practical Nurses in a fraction of the usual time, opening doors to entry-level positions in healthcare.

Specializations are also available. The fastest psych np program lets you focus on psychiatric and mental health nursing, a rapidly growing area with high demand.

Exploring these varied pathways can help you find the best option for starting or advancing your healthcare career in the USA.

Best Scientists Citing Sarah S. Donaldson

Trending Scientists

Recently Published Articles